JIPYONG LLC

Jipyong News|News

Jipyong Launches AI, Bio & Healthcare Center

2026.01.30

On January 30, 2026, Jipyong launched the AI, Bio & Healthcare Center to provide specialized legal services drawing on technical knowledge and regulatory expertise in the bio and healthcare sectors. 
 
Jipyong has strengthened its technology advisory capabilities through close collaboration with Jipyong IP, the firm’s affiliated patent firm.  Building on this partnership, the firm expanded its former Bio & Healthcare Team into the AI, Bio & Healthcare Center, bringing together specialists across the pharmaceutical, bio, medical device, and healthcare fields.  Jipyong IP oversees the technology and intellectual property matters at the core of these industries, providing seamless counsel from research and development through commercialization. 
 
The Center is co-headed by Of Counsel Yoomi KIM, and Partner Tae Hyun LEE.  Ms. KIM is a regulatory and administrative expert with approximately 18 years of experience at the Ministry of Food and Drug Safety (MFDS), where she oversaw policy on pharmaceuticals, medical devices, and food safety.  Mr. LEE brings extensive M&A experience and actively advises on investments in the pharmaceutical, bio, and healthcare sectors.  Jin Joo JEONG, a Partner who graduated top of her class from a college of pharmacy and holds a master’s degree in pharmaceutical sciences, serves as Deputy Head.  Other key members include Seung Soo CHOI, who serves as outside counsel to the MFDS; Sung Soo KIM, a physician-turned-attorney specializing in medical litigation; Yoon Jeong JANG, former Non-Standing Director of the Korea Occupational Safety and Health Agency (KOSHA); Jun Hee SEO, a Partner advising pharmaceutical, bio, and medical-sector clients; Jong HEO, a sitting board member of the Korean Intellectual Property Lawyers Association; and Yu Jin LEE, who advises on IPOs and capital markets transactions. 
 
The Center’s practice spans seven core areas: (i) regulatory compliance for the healthcare, bio, pharmaceutical, and medical device industries; (ii) intellectual property advisory; (iii) licensing, collaboration, partnership, and joint venture structures; (iv) commercial contracts for the bio, pharmaceutical, and medical device sectors; (v) M&A and investment; (vi) IPOs and capital markets; and (vii) litigation and arbitration.  Leveraging its expertise, the Center delivers optimal solutions for clients navigating the complex regulatory landscape of the healthcare and life sciences industries and provides comprehensive support for their business growth. 
 
Yoomi KIM, Of Counsel and Co-Head of Jipyong’s AI Bio & Healthcare Center, said, “As technological innovation accelerates, the regulatory environment across the healthcare industry—both domestically and internationally—is rapidly evolving, driving increased demand for integrated and comprehensive advisory services."  "The AI, Bio & Healthcare Center is committed to being a strategic partner that supports clients’ decision-making through deep industry knowledge and practical experience.” 
 
[Korean Article Reference]

<ul>
	<li><a href="https://www.ajunews.com/view/20260202142330456">Aju Press— “Jipyong Launches ‘AI, Bio & Healthcare Center’“ (Feb. 2, 2026)</a></li>
	<li><a href="https://www.joseilbo.com/news/htmls/2026/02/20260202562072.html">Joseilbo — “Jipyong Launches ‘AI, Bio & Healthcare Center’; Yoomi KIM and Tae Hyun LEE Named Co-Heads” (Feb. 2, 2026)</a></li>
</ul>
 
[Photo]

<div>(Front row, from left, counterclockwise) Sung Soo KIM (Partner); Yoon-sun KIM (Patent Attorney & Partner, Jipyong IP); Tae Hyun LEE (Partner & Co-Head); Jin Joo JEONG (Partner & Deputy Head); Yoomi KIM (Of Counsel & Co-Head); Haeng Gyu LEE (Managing Partner); Hyuk-sung KWON (Patent Attorney & Managing Partner, Jipyong IP); Jong HEO (Partner); Da Young KANG (Associate); Joon Woo CHUN (Associate); Iy Soo HWANG (Senior Advisor); Byoung Whan MIN (Senior Advisor); Jin Kwon KIM (Partner); Yong Woo SHIN (Partner); Jong Yun KIM (Foreign Attorney); Andrew M. LEE (Foreign Attorney); Yu Jin LEE (Partner); Suk-kyung HONG (Patent Attorney & Partner, Jipyong IP); Yoon Jeong JANG (Partner); John C. W. RO (Foreign Attorney); and Jun Hee SEO (Partner)</div>

KOREA LEGAL INSIGHT The Transition of Korea’s ESG Regulatory Framework from Guidance to Enforcement: What Global Businesses Should Watch for in 2026 2026.02.02

KOREA LEGAL INSIGHT Set-off in Korean Rehabilitation Proceedings: Limits and Practical Risks for Foreign Creditors 2026.01.19

Back to List

JIPYONG LLC

Related Practices

Professionals

Related Practices

Professionals

SHARE

Disclaimer

Limited Liabilities